Heron Therapeutics(CH:AXD2)
CH:AXD2
Heron Therapeutics earnings date
Heron Therapeutics (AXD2) Q3 2023 Earnings Report
9 Followers
CH:AXD2 Q3 2023 EPS Results
- Actual EPS
- -CHF 0.14
- Consensus EPS
- -CHF 0.24
- Beat/Miss
- Beat by +CHF 0.10
- One Year Ago EPS
- -CHF 0.31
CH:AXD2 Q3 2023 Revenue Results
- Actual Revenue
- CHF 25.95M
- Expected Revenue
- CHF 26.95M
- Beat/Miss
- Missed by -CHF 1.00M
- YoY Revenue Growth
- +18.36%
Earnings Announcement Details
- Quarter
- Q3 2023
- Date
- 11/14/2023
- Time
- After Close
- Conference Call
- Tuesday, November 14, 2023
CH:AXD2 Upcoming Earnings
Heron Therapeutics's next earnings date is estimated for March 4, 2027, based on past reporting schedules.
Q3 2023 Earnings Call Audio
CH:AXD2 Q3 2023 Earnings Call
0:00 / 0:00
Q3 2023 Earnings Slide Deck
Q3 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:AXD2 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 04, 2027 | 2026 (Q4) | -0.02- | -0.02 | ― | ― |
| Nov 09, 2026 | 2026 (Q3) | -0.02-0.02 | -0.08 | 70.00% (+0.06) | |
| Aug 10, 2026 | 2026 (Q2) | -0.00-0.02 | -0.02 | -50.00% (-0.01) | |
| May 11, 2026 | 2026 (Q1) | -0.02-0.03 | 0.01 | -500.00% (-0.04) | |
| Feb 26, 2026 | 2025 (Q4) | -0.02-0.02 | 0.02 | -200.00% (-0.03) | |
| Nov 04, 2025 | 2025 (Q3) | -0.01-0.08 | -0.02 | -233.33% (-0.06) | |
| Aug 08, 2025 | 2025 (Q2) | -0.01-0.02 | -0.05 | 66.67% (+0.03) | |
| May 06, 2025 | 2025 (Q1) | -0.000.01 | -0.02 | 150.00% (+0.02) | |
| Feb 27, 2025 | 2024 (Q4) | -0.030.02 | -0.06 | 128.57% (+0.07) | |
| Nov 12, 2024 | 2024 (Q3) | -0.03-0.02 | -0.14 | 82.35% (+0.12) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
